4ZYP
Crystal Structure of Motavizumab and Quaternary-Specific RSV-Neutralizing Human Antibody AM14 in Complex with Prefusion RSV F Glycoprotein
Summary for 4ZYP
Entry DOI | 10.2210/pdb4zyp/pdb |
Related | 4ZYK |
Descriptor | Fusion glycoprotein F0,Fibritin, Motavizumab antibody Fab heavy chain, Motavizumab antibody light chain, ... (5 entities in total) |
Functional Keywords | ig domain, fab, immune system, fusion, respiratory syncytial virus, prefusion |
Biological source | Human respiratory syncytial virus A (strain A2) More |
Total number of polymer chains | 15 |
Total formula weight | 451609.35 |
Authors | Gilman, M.S.A.,McLellan, J.S. (deposition date: 2015-05-21, release date: 2015-07-29, Last modification date: 2023-09-27) |
Primary citation | Gilman, M.S.,Moin, S.M.,Mas, V.,Chen, M.,Patel, N.K.,Kramer, K.,Zhu, Q.,Kabeche, S.C.,Kumar, A.,Palomo, C.,Beaumont, T.,Baxa, U.,Ulbrandt, N.D.,Melero, J.A.,Graham, B.S.,McLellan, J.S. Characterization of a Prefusion-Specific Antibody That Recognizes a Quaternary, Cleavage-Dependent Epitope on the RSV Fusion Glycoprotein. Plos Pathog., 11:e1005035-e1005035, 2015 Cited by PubMed: 26161532DOI: 10.1371/journal.ppat.1005035 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (5.5 Å) |
Structure validation
Download full validation report